1. Home
  2. MPTI vs ACRS Comparison

MPTI vs ACRS Comparison

Compare MPTI & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$92.59

Market Cap

350.9M

Sector

N/A

ML Signal

HOLD

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$4.44

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
ACRS
Founded
1965
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.9M
311.0M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
MPTI
ACRS
Price
$92.59
$4.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$71.00
$10.20
AVG Volume (30 Days)
56.4K
1.1M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.01
EPS
0.67
N/A
Revenue
$54,417,000.00
$1,683,000.00
Revenue This Year
$11.06
N/A
Revenue Next Year
$12.15
$4.24
P/E Ratio
$135.36
N/A
Revenue Growth
11.03
N/A
52 Week Low
$36.38
$1.34
52 Week High
$90.69
$5.15

Technical Indicators

Market Signals
Indicator
MPTI
ACRS
Relative Strength Index (RSI) 75.58 46.79
Support Level $60.13 $4.15
Resistance Level N/A $4.56
Average True Range (ATR) 4.19 0.21
MACD 1.14 -0.05
Stochastic Oscillator 91.48 19.02

Price Performance

Historical Comparison
MPTI
ACRS

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: